Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
66,451
Value
$2.22M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RARE by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202666,451$2.22M<0.1%+52,253+368.0%AddedHolders
Q1 202614,198$297.4K<0.1%−2,444−14.7%ReducedHolders
Q4 202516,642$382.8K<0.1%−19,692−54.2%ReducedHolders
Q3 202536,334$1.09M<0.1%+22,345+159.7%AddedHolders
Q2 202513,989$508.6K<0.1%−2,517−15.2%ReducedHolders
Q1 202516,506$597.7K<0.1%−527,696−97.0%ReducedHolders
Q4 2024544,202$22.9M<0.1%+527,180+3,097.1%AddedHolders
Q3 202417,022$945.6K<0.1%−264,071−93.9%ReducedHolders
Q2 2024281,093$11.6M<0.1%−87,126−23.7%ReducedHolders
Q1 2024368,219$17.2M<0.1%−794,858−68.3%ReducedHolders
Q4 20231,163,077$55.6M0.1%−38,611−3.2%ReducedHolders
Q3 20231,201,688$42.8M0.1%+46,852+4.1%AddedHolders
Q2 20231,154,836$53.3M0.1%−57,780−4.8%ReducedHolders
Q1 20231,212,616$48.6M0.1%+68,644+6.0%AddedHolders
Q4 20221,143,972$53.0M0.1%+459,628+67.2%AddedHolders
Q3 2022684,344$28.3M<0.1%+118,699+21.0%AddedHolders
Q2 2022565,645$33.7M<0.1%−158,113−21.8%ReducedHolders
Q1 2022723,758$52.6M0.1%−18,883−2.5%ReducedHolders
Q4 2021742,641$62.4M0.1%+25,533+3.6%AddedHolders
Q3 2021717,108$64.7M0.1%+123,165+20.7%AddedHolders
Q2 2021593,943$56.6M0.1%+35,364+6.3%AddedHolders
Q1 2021558,579$63.6M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.